Asthma Drug Xolair Linked to Severe Brain, Heart Issues, Pharmaceutical … – Business Wire (press release)

Asthma Drug Xolair Linked to Severe Brain, Heart Issues, Pharmaceutical
Business Wire (press release)
DALLAS–(BUSINESS WIRE)–Xolair, a drug used to treat allergic asthma in adults and children 12 years and older, has been linked to significant health issues such as mini-strokes, heart attacks and blood clots, the national law firm of Baron and Budd

and more »

View full post on asthma – Google News

Research and Markets: Roche/Genentech/Novartis’ Asthma Treatment – Xolair … – Business Wire (press release)

Research and Markets: Roche/Genentech/Novartis' Asthma Treatment – Xolair
Business Wire (press release)
Roche/Genentech/Novartis' Xolair (omalizumab) is currently the only FDA-approved biologic used in the treatment of asthma. This drug is a recombinant humanized mAb that binds and neutralizes IgE with the same high affinity as its cognate receptor, FceRI.
Research and Markets: Merck's Dulera Asthma Treatment – Forecast and Market DigitalJournal.com

all 2 news articles »

View full post on asthma – Google News

FDA says asthma drug Xolair raises risk of heart, brain problems – MSN Philippines News

FDA says asthma drug Xolair raises risk of heart, brain problems
MSN Philippines News
WASHINGTON – The asthma drug Xolair is associated with a higher risk of heart attack, mini-stroke, chest pain and blood clots in the lungs and veins, among other problems, though the extent of increased risk is unclear, the U.S. Food and Drug

and more »

View full post on asthma – Google News

FDA slaps cardiovascular warnings on Roche/Novartis asthma blockbuster Xolair – FiercePharma


Fox News

FDA slaps cardiovascular warnings on Roche/Novartis asthma blockbuster Xolair
FiercePharma
It was way back in 2009 when the FDA first indicated it was worried about reports of heart attacks and strokes in patients taking Xolair, the asthma treatment co-marketed by Novartis ($NVS) and Roche ($RHHBY). Now the agency is taking action, slapping …
FDA says asthma drug Xolair raises risk of heart, brain problemsFox News
Heart, Mini-Stroke Risks From Asthma Drug: FDAWebMD
FDA adds cardiovascular risks to Xolair label for asthma treatmentHealio
ModernMedicine
all 6 news articles »

View full post on asthma – Google News

UPDATE 1-FDA says asthma drug Xolair raises risk of heart, brain problems – Reuters


GlobalPost

UPDATE 1-FDA says asthma drug Xolair raises risk of heart, brain problems
Reuters
Xolair is an injectible drug that was originally approved in 2003 to treat moderate to severe asthma in adults and children aged 12 or over whose condition was not controlled by inhaled steroids. The drug is also approved to treat chronic idiopathic
FDA says asthma drug Xolair raises risk of heart, brain problemsYahoo News
FDA warns of increased risks of asthma drug XolairAAP News (subscription)
FDA: Asthma Drug May Increase Risk of CV, Cerebrovascular EventsMonthly Prescribing Reference

all 19 news articles »

View full post on asthma – Google News

FDA warns of increased risks of asthma drug Xolair – AAP News (subscription)


GlobalPost

FDA warns of increased risks of asthma drug Xolair
AAP News (subscription)
Patients receiving the asthma medication Xolair (omalizumab) may have a slightly higher risk of serious adverse events affecting the cardiovascular and cerebrovascular systems, according to a review by the Food and Drug Administration (FDA). In
FDA: Asthma Drug May Increase Risk of CV, Cerebrovascular EventsMonthly Prescribing Reference

all 15 news articles »

View full post on asthma – Google News

FDA says asthma drug Xolair raises risk of heart, brain problems – Yahoo News


GlobalPost

FDA says asthma drug Xolair raises risk of heart, brain problems
Yahoo News
WASHINGTON (Reuters) – The asthma drug Xolair is associated with a higher risk of heart attack, mini-stroke, chest pain and blood clots in the lungs and veins, among other problems, though the extent of increased risk is unclear, the U.S. Food and Drug …
FDA warns of increased risks of asthma drug XolairAAP News (subscription)
FDA: Asthma Drug May Increase Risk of CV, Cerebrovascular EventsMonthly Prescribing Reference

all 13 news articles »

View full post on asthma – Google News

FDA says asthma drug Xolair raises risk of heart, brain problems – Reuters

FDA says asthma drug Xolair raises risk of heart, brain problems
Reuters
WASHINGTON (Reuters) – The asthma drug Xolair is associated with a higher risk of heart attack, mini-stroke, chest pain and blood clots in the lungs and veins, among other problems, though the extent of increased risk is unclear, the U.S. Food and Drug …
FDA: Asthma Drug May Increase Risk of CV, Cerebrovascular EventsMonthly Prescribing Reference
FDA warns of increased risks of asthma drug XolairAAP News (subscription)
Xolair (omalizumab): Drug Safety Communication – Slightly Elevated Risk of Food Consumer

all 8 news articles »

View full post on asthma – Google News